Delayed but Not Denied: France Finally Unveils Full Medical Cannabis Blueprint

Augur Associates' CEO, Benjamin-Alexandre Jeanroy, sheds light on the recent French medical cannabis regulatory announcements, which will enable product registration to begin in 2025.

“We’re just waiting for what I call ‘bureaucratic suspense’ to finalise, and then the government will sign the decrees once they’ve been signed off by the EU. That usually happens during the ministerial meetings every Wednesday at the presidential palace, but that’s usually a formality.”

Read more on Business of Cannabis here.